Funding

Congruence Therapeutics

Canada · Biotech · AI · Enterprise software

Develops small molecule correctors for diseases of protein misfolding

Visit congruencetx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$39.5MAmplitude Ventures — Role not disclosedBDC Capital's Thrive Venture Fund — Role not disclosedDimension — Role not disclosedDriehaus Capital Management — Role not disclosedFonds de solidarité FTQ — Role not disclosedInvestissement Québec — Role not disclosedLumira Ventures — Role not disclosedOrbiMed — Role not disclosedSilver Arc — Role not disclosed

Investors

Amplitude VenturesSeries BBDC Capital's Thrive Venture FundSeries BDimensionSeries BDriehaus Capital ManagementSeries BFonds de solidarité FTQSeries BInvestissement QuébecSeries BLumira VenturesSeries BOrbiMedSeries BSilver ArcSeries B

Coverage

Mar 19, 2026Congruence Therapeutics · Series B

Similar companies

Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
GasLabGasLab is developing a generative music platform that links AI-created tracks to participating artists and rights holders so they can share in the revenue.~$1M · Pre-seed
HoloHolo helps small businesses plan marketing campaigns, create content and publish it across connected channels.€5M · Seed
Sourcescongruencetx.com ↗